Canadian Consortium on Neurodegeneration in Aging (CCNA)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2014
  • Initiating Organization: Canadian Institutes of Health Research
  • Initiator Type: Government
  • Disease focus:
    Alzheimer's Disease
  • Location: North America


The Canadian Consortium on Neurodegeneration in Aging (CCNA) focuses on research into the basic mechanisms of neurodegenerative diseases, accelerating the development of tools that can be used to assist in the diagnosis and treatment of the diseases. The intended outcome of these tools is to improve the quality of life and services for patients with neurodegenerative diseases.


As part of the Canadian contribution to the International Collaborative Research Strategy for Alzheimer’s disease, CCNA brings together Canadian government agencies (federal and provincial), foundations, pharmaceutical companies, philanthropists, and international stakeholders to identify whether there are common causes and risk factors to neurodegenerative diseases.

Structure & Governance

CCNA will be led by one nominated principal investigator, supported by three principal investigators for each of the three research themes: Primary Prevention, Secondary Prevention, and Quality of Life.


The consortium receives C$31.5 million from the federal government and several partners (such as the Alzheimer Society of Canada, which contributes C$4.0 million), as well as an additional C$24.0 million from partners in Ontario and Quebec.

Intellectual Property

Intellectual property guidelines follow those for any grant issued by the Canadian Institutes of Health Research (CIHR). Specifically, CIHR does not retain or claim any ownership of, or exploitation or proprietary rights to, intellectual property, copyright, or inventions developed/resulting from research supported with grant funds and does not pass judgment on the eventual commercial success of the research.

Should grantees decide to pursue commercialization of any results of the research, including all partnered initiatives, they must adhere to institutional and CIHR policies governing the assignment of intellectual property. 

Patient Engagement

The Alzheimer Society of Canada and Alzheimer’s Research UK are founders and financial contributors to the consortium.

Points of Contact

Joanne Goldberg
Assistant Director
CIHR Institute of Aging
phone: 514-360-2433

Michelle Peel
Assistant Director
CIHR Institute of Aging
phone: 613-952-4537

Sponsors & Partners

Alberta Prion Research Institute

Alzheimer Society of Canada

Alzheimer’s Research UK

Canadian Institutes of Health Research

Canadian Nurses Foundation

Fonds de recherche du Québec - Santé

International Collaborative Research Strategy for Alzheimer’s Disease

Michael Smith Foundation for Health Research

Ontario Brain Institute

Pfizer, Inc.

Robin and Barry Picov Foundation

Sanofi S.A.

The New Brunswick Health Research Foundation

The Nova Scotia Health Research Foundation

The Saskatchewan Health Research Foundation

Women’s Brain Health Initiative

Last Updated: 04/07/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.